Solid phase immunoadsorption for therapeutic and analytical studies on neuropathy-associated anti-GM1 antibodies

Glycobiology

Volumn 17, Issue 3, 2007, Pages 294-303

  Townson, Kate ^a   Boffey, Judith ^a   Nicholl, Dawn ^a   Veitch, Jean ^a   Bundle, David ^b   Zhang, Ping ^b   Samain, Eric ^c   Antoine, Tatiana ^c   Bernardi, Anna ^d   Arosio, Daniela ^d   Sonnino, Sandro ^d   Isaacs, Neil ^a   Willison, Hugh J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF ALBERTA   (Canada)

^c CENTRE DE RECHERCHES SUR LES MACROMOLÉCULES VÉGÉTALES CERMAV CNRS   (France)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM1; GLYCAN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MONOCLONAL ANTIBODY; MONOSACCHARIDE; PARAPROTEIN; PENTASACCHARIDE; SEPHAROSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; GUILLAIN BARRE SYNDROME; HUMAN; HUMORAL IMMUNITY; IMMUNOADSORPTION; LYMPHOCYTE COUNT; MOLECULAR CLONING; MOUSE; NEUROPATHY; NONHUMAN; PLASMAPHERESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN PURIFICATION; SEROLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; G(M1) GANGLIOSIDE; HUMANS; MICE; MICE, KNOCKOUT; OLIGOSACCHARIDES; PLASMAPHERESIS; SORPTION DETOXIFICATION;

EID: 33847193765     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwl074     Document Type: Article

References (49)

1. Andersen SM, Ling CC, Zhang P, Townson K, Willison HJ, Bundle DR. 2004. Synthesis of ganglioside epitopes for oligosaccharide specific immunoadsorption therapy of Guillian-Barré syndrome. Org Biomol Chem. 2:1199-1212.
2. Antoine T, Priem B, Heyraud A, Greffe L, Gilbert M, Wakarchuk WW, Lam JS, Samain E. 2003. Large-scale in vivo synthesis of the carbohydrate moieties of gangliosides GM1 and GM2 by metabolically engineered Escherichia coli. Chembiochem. 4:406-412.
3. Arosio D, Vrasidas I, Valentini P, Liskamp RMJ, Pieters RJ, Bernardi A. 2004. Synthesis and cholera toxin binding properties of multivalent GM1 mimics. Org Biomol Chem. 2:2113-2124.
4. Aspinall GO, Mcdonald AG, Pang H, Kurjanczyk LA, Penner JL. 1994. Lipopolysaccharides of Campylobacter jejuni serotype-O-19 - structures of core oligosaccharide regions from the serostrain and 2 bacterial isolates from patients with the Guillain-Barré-syndrome. Biochemistry. 33: 241-249.
5. Bannett AD, McAlack RF, Raja R, Baquero A, Morris M. 1987. Experiences with known ABO-mismatched renal transplants. Transplant Proc. 19: 4543-4546.
6. Bernardi A, Carrettoni L, Ciponte AG, Monti D, Sonnino S. 2000. Second generation mimics of ganglioside GM1 as artificial receptors for cholera toxin: Replacement of the sialic acid moiety. Bioorg Med Chem Lett. 10: 2197-2200.
7. Boffey J, Nicholl D, Wagner ER, Townson K, Goodyear C, Furukawa K, Furukawa K, Conner J, Willison HJ. 2004. Innate murine B cells produce anti-disialosyl antibodies reactive with Campylobacter jejuni LPS and gangliosides that are polyreactive and encoded by a restricted set of unmutated V genes. J Neuroimmunol. 152:98-111.
8. Boffey J, Odaka M, Nicoll D, Wagner ER, Townson K, Bowes T, Conner J, Furukawa K, Willison HJ. 2005. Characterisation of the immunoglobulin variable region gene usage encoding the murine anti-ganglioside antibody repertoire. J Neuroimmunol. 165:92-103.
9. Bowes T, Wagner ER, Boffey J, Nicholl D, Cochrane L, Benboubetra M, Conner J, Furukawa K, Furukawa K, Willison HJ. 2002. Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome. Infect Immun. 70:5008-5018.
10. Bundle DR, Baumann H, Brisson JR, Gagne SM, Zdanov A, Cygler M. 1994. Solution structure of a trisaccharide-antibody complex: Comparison of NMR measurements with a crystal structure. Biochemistry. 33(17): 5183-5192.
11. Bundle DR. 1998. Recognition of carbohydrate antigens by antibody binding sites. In: Hecht S, editor. Carbohydrates. Oxford (UK): Oxford University Press Inc.; p. 370-440.
12. Calarese DA, Scanlan CN, Zwick MB, Deechongkit S, Mimura Y, Kunert R, Zhu P, Wormald MR, Stanfield RL, Roux KH, Kelly JW, Rudd PM, Dwek RA, Katinger H, Burton DR, Wilson IA. 2003. Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science. 300:2065-2071.
13. Cygler M, Rose DR, Bundle DR. 1991. Recognition of a cell-surface oligosaccharide of pathogenic Salmonella by an antibody Fab fragment. Science 253(5018):442-445.
14. Feizi T, Childs RA, Watanabe K, Hakomori SI. 1979. Three types of blood group I specificity among monoclonal anti-I autoantibodies revealed by analogues of a branched erythrocyte glycolipid. J Exp Med. 149: 975-980.
15. Fort S, Birikaki L, Dubois MP, Antoine T, Samain E, Driguez H. 2005. Biosynthesis of conjugatable saccharidic moieties of GM2 and GM3 gangliosides by engineered E. coli. Chem Commun. 20:2558-2560.
16. Goodyear CS, O'Hanlon GM, Plomp JJ, Wagner ER, Morrison I, Veitch J, Cochrane L, Bullens RWM, Molenaar PC, Conner J, Willison HJ. 1999. Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyse nerve muscle preparations. J Clin Invest. 104: 697-708.
17. Gooi HC, Feizi T, Kapadia A, Knowles BB, Solter D, Evans MJ. 1981. Stage-specific embryonic antigen involves αp1-3 fucosylated type 2 blood group chains. Nature. 292:156-158.
18. Gorson KC, Ropper AH, Adelman LS, Raynor M, Saper CB. 1999. Chronic motor axonal neuropathy: Pathological evidence of inflammatory polyradiculoneuropathy. Muscle Nerve. 22(2):266-270.
19. Kabat EA, Liao J, Shyong J, Osserman EF. 1982. A monoclonal IgM lambda macroglobulin with specificity for lacto-N-tetraose in a patient with bronchogenic carcinoma. J Immunol. 128:540-544.
20. Krengel U, Olsson LL, Martinez C, Talavera A, Rojas G, Mier E, Angstrom J, Moreno E. 2004. Structure and molecular interactions of a unique antitumor antibody specific for N-glycolyl GM3. J Biol Chem. 279: 5597-5603.
21. Lambrigts D, Van Calster P, Xu Y, Awwad M, Neethling FA, Kozlowski T. 1988. Pharmacologic immunosuppressive therapy and extracorporeal immunoadsorption in the suppression of anti-αGal antibody in the baboon. Xenotransplantation. 5:274-283.
22. Landers JL, Cao Z, Lee I, Piehler LT, Myc PP, Myc A, Hamounda T, Galecki AT, Baker JR. 2002. Prevention of Influenza pneumonitis by sialic acid-conjugated dendritic polymers. J Infect Dis. 186(9): 1222-1230.
23. Lanne B, Schierbeck B, Angstrom J. 1999. Binding of cholera toxin B-subunits to derivatives of the natural ganglioside, receptor, GM1. J Biochem. 126(1):226-234.
24. Lanne B, Schierbeck B, Karlsson KA. 1994. On the role of the carboxyl group of sialic acid in binding of cholera toxin to the receptor, glycosphingolipid, GM1. J Biochem. 116(6):1269-1274.
25. Lee J, Cairns T, McKane W, Rashid M, George AJ, Taube D. 1998. Demonstration of IgM antibodies of high affinity within the anti-Galαp1-3Gal antibody repertoire. Transplantation 66(8): 1117-1119.
26. Lefranc MP. 2003. IMGT, the international ImMunoGeneTics database. Nucleic Acids Res. 31(1):307-310.
27. Merritt EA, Sarfaty S, van der Akker F, L'Hoir C, Martial JA, Hol WG. 1994. Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharide. Protein Sci. 3(2):166-175.
28. Nagahori N, Lee RT, Nishimura S, Pagé D, Roy R, Lee YC. 2002. Inhibition of adhesion of Type 1 fimbriated Escherichia coli to highly mannosylated ligands. Chembiochem. 3:836-844.
29. Nguyen HP, Seto NLO, MacKenzie CR, Brade L, Kosma P, Brade H, Evans SV. 2003. Germline antibody recognition of distinct carbohydrate epitopes. Nat Struct Biol. 10(12):1019-1025.
30. Pichla SL, Murali R, Burnett RM. 1997. The crystal structure of a Fab fragment to the melanoma-associated GD2 ganglioside. J Struct Biol. 119: 6-16.
31. Ramsland PA, Farrugia W, Bradford TM, Mark Hogarth P, Scott AM. 2004. Structural convergence of antibody binding of carbohydrate determinants in Lewis Y tumor antigens. J Mol Biol. 340:809-818.
32. Sablinski T, Latinne D, Gianello P, Bailin M, Bergen K, Colvin RB, Foley A, Hong H-Z, Lorf T, Meehan S, Monroy R, Powelson JA, Sykes M, Tanaka M, Cosimi AB, Sachs DH. 1995. Xenotransplantation of pig kidneys to non-human primates: 1. Development of the model. Xenotransplantation. 2:264-270.
33. Schengrund CL. 2003. "Multivalent" saccharides: Development of new approaches for inhibiting the effects of glycosphingolipid-binding pathogens. Biochem Pharmacol. 65:699-707.
34. Spangler BD. 1992. Structure and function of cholera toxin and the related Escherichia coli heat labile enterotoxin. Microbiol Rev. 56(4): 622-647.
35. Svennerholm L. 1980. Ganglioside designation. Adv Exp Med Biol. 125:11.
36. Taniguchi S, Neethling FA, Korchagina EY, Bovin N, Ye Y, Kobayashi T. 1996. In vivo immunoadsorption of anti-pig antibodies in baboons using a specific Gal(α)1-3Gal column. Transplantation. 62:1379-1384.
37. Tettamanti G. 2004. Ganglioside/glycosphingolipid turnover: New concepts. Glycoconj J. 20:301-317.
38. van Roon AM, Pannu NS, de Vrind JPM, van der Marel GA, van Boom JH, Hokke CH, Deelder AM, Abrahams JP. 2004. Structure of an anti-Lewis X Fab fragment in complex with its Lewis X antigen. Structure. 12: 1227-1236.
39. Villeneuve S, Souchon H, Riottot MM, Mazie JC, Lei P, Glaudemans CPJ, Kovac P, Fournier JM, Alzari PM. 2000. Crystal structure of an anti-carbohydrate antibody directed against Vibrio cholerae O1 in complex with antigen: Molecular basis for serotype specificity. Proc Natl Acad Sci USA. 97:8433-8438.
40. Vyas AA, Patel HV, Fromholt SE, Heffer-Lauc M, Vyas KA, Dang J, Schachner M, Schnaar RL. 2002. Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration. Proc Natl Acad Sci USA. 99:8412-8417.
41. Wiegandt H, Bucking HW. 1970. Carbohydrate components of extraneuronal gangliosides from bovine and human, spleen, and bovine kidney. Eur J Biochem. 15:287-292.
42. Willison HJ. 2005. The immunobiology of Guillain-Barré syndromes. J Peripher Nerv Syst. 10:94-112.
43. Willison HJ, O'Hanlon GM. 1999. The immunopathogenesis of Miller Fisher syndrome. J Neuroimmunol. 100:3-12.
44. Willison HJ, Paterson G, Kennedy PGE, Veitch J. 1994. Cloning of human anti-GM1 antibodies from motor neuropathy patients. Ann Neurol. 35: 471-478.
45. Willison HJ, Townson K, Veitch J, Boffey J, Isaacs N, Andersen SM, Zhang P, Ling CC, Bundle DR. 2004. Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera. Brain. 127:680-691.
46. Willison HJ, Yuki N. 2002. Peripheral neuropathies and anti-glycolipid antibodies. Brain. 125:2591-2625.
47. Willison HJ, Veitch J. 1994. Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller Fisher syndrome. J Neuroimmunol. 50:159-165.
48. Xu G, Lorf T, Sablinski T, Gianello P, Bailin M, Monroy R, Kozlowski T, Awwad M, Cooper DK, Sachs DH. 1998. Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a Galαp1-3Galβp1-4βGlc-X immunoaffinity column. Transplantation. 65(2):172-179.
49. Zdanov A, Li Y, Bundle DR, Deng S, MacKenzie CR, Narang SA, Young NM, Cygler M. 1994. Structure of a single-chain antibody variable domain (Fv) fragment complexed with a carbohydrate antigen at 1.7-A resolution. Proc Natl Acad Sci USA. 91:6423-6427.